266 related articles for article (PubMed ID: 34251279)
1. One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
Feng Z; Yang S; Sang H; Xue G; Ni Q; Zhang L; Zhang W; Fang X; Ye M
J Endovasc Ther; 2021 Dec; 28(6):927-937. PubMed ID: 34251279
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
3. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
Stavroulakis K; Schwindt A; Torsello G; Beropoulis E; Stachmann A; Hericks C; Bollenberg L; Bisdas T
J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study.
Pan D; Guo J; Su Z; Meng W; Wang C; Guo J; Gu Y
Ann Vasc Surg; 2024 Feb; 99():26-32. PubMed ID: 37914073
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
[TBL] [Abstract][Full Text] [Related]
6. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
8. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
[TBL] [Abstract][Full Text] [Related]
9. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
[TBL] [Abstract][Full Text] [Related]
10. Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
Rocha-Singh KJ; Sachar R; DeRubertis BG; Nolte-Ernsting CCA; Winscott JG; Krishnan P; Scott EC; Garcia LA; Baeriswyl JL; Ansel G; Rosenfield K; Zeller T;
Catheter Cardiovasc Interv; 2021 Sep; 98(3):549-558. PubMed ID: 34080792
[TBL] [Abstract][Full Text] [Related]
11. Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.
Zeller T; Langhoff R; Rocha-Singh KJ; Jaff MR; Blessing E; Amann-Vesti B; Krzanowski M; Peeters P; Scheinert D; Torsello G; Sixt S; Tepe G;
Circ Cardiovasc Interv; 2017 Sep; 10(9):e004848. PubMed ID: 28916599
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
Stavroulakis K; Bisdas T; Torsello G; Argyriou A; Bollenberg L; Schwindt A
J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
[TBL] [Abstract][Full Text] [Related]
13. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
Foley TR; Cotter RP; Kokkinidis DG; Nguyen DD; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
[TBL] [Abstract][Full Text] [Related]
14. Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.
Yiğit G
Vascular; 2022 Aug; 30(4):739-748. PubMed ID: 34180304
[TBL] [Abstract][Full Text] [Related]
15. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
Yu C; Tang W; Ren T; Chen Q; Lu R; Gao Y
J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
[TBL] [Abstract][Full Text] [Related]
16. JetStream Atherectomy for the Treatment of In-Stent Restenosis of the Femoropopliteal Segment: One-Year Results of the JET-ISR Study.
Shammas NW; Petruzzi N; Henao S; Armstrong EJ; Shimshak T; Banerjee S; Latif F; Eaves B; Brothers T; Golzar J; Shammas GA; Jones-Miller S; Christensen L; Shammas WJ
J Endovasc Ther; 2021 Feb; 28(1):107-116. PubMed ID: 32885736
[TBL] [Abstract][Full Text] [Related]
17. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
Cai Z; Guo L; Qi L; Cui S; Tong Z; Guo J; Wang Z; Gu Y
Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
[TBL] [Abstract][Full Text] [Related]
18. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
19. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
Kokkinidis DG; Jawaid O; Cantu D; Martinsen BJ; Igyarto Z; Valle JA; Waldo SW; Armstrong EJ
J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
[No Abstract] [Full Text] [Related]
20. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
